Location History:
- Bornem, BE (2016)
- Grimbergen, BE (2018)
- Humbeek, BE (2020)
Company Filing History:
Years Active: 2016-2020
Title: Jan Emiel Godelieve Vertommen: Innovator in Oral Dosage Forms
Introduction
Jan Emiel Godelieve Vertommen is a notable inventor based in Humbeek, Belgium. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative oral dosage forms. With a total of three patents to his name, Vertommen's work focuses on enhancing the efficiency and effectiveness of drug delivery systems.
Latest Patents
Among his latest patents is a groundbreaking printing process for oral dosage forms. This process involves several steps, including providing a plurality of dosage forms filled with a liquid composition, transferring them to a printing station, and printing indicia over each dosage form. The printed dosage forms are then inspected and sorted based on predetermined characteristics. Dosage forms that do not meet these characteristics are collected for further processing, ensuring quality control in pharmaceutical manufacturing. Another significant patent is for stable dosage form articles for oral administration. This invention features a novel gelatin-based dosage form that can contain active materials capable of reacting with gelatin, enhancing the stability and efficacy of the drug delivery system.
Career Highlights
Jan Emiel Godelieve Vertommen is currently employed at Capsugel Belgium NV, a company renowned for its expertise in developing and manufacturing dosage forms. His work at Capsugel has allowed him to push the boundaries of pharmaceutical innovation, contributing to advancements that benefit both manufacturers and patients.
Collaborations
Throughout his career, Vertommen has collaborated with talented individuals such as Sylvain Thomazic and Vincent Bechtel. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of cutting-edge technologies in the pharmaceutical sector.
Conclusion
Jan Emiel Godelieve Vertommen stands out as a key figure in the field of oral dosage form innovation. His patents reflect a commitment to improving drug delivery systems, ultimately enhancing patient care. His contributions continue to shape the future of pharmaceutical technology.